These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 21735853)

  • 1. [Cost of lost productivity in pharmacoeconomics analysis. Part II. Survey in the expert group].
    Wrona W; Hermanowski T; Jakubczyk M; Golicki D; Czech M; Niewada M; Kolasa K
    Przegl Epidemiol; 2011; 65(1):153-7. PubMed ID: 21735853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cost of lost productivity in pharmacoeconomics analysis. Part I. A systematic review of the literature].
    Wrona W; Hermanowski T; Golicki D; Jakubczyk M; Macioch T; Goszczyńska K; Wójcik R
    Przegl Epidemiol; 2011; 65(1):147-52. PubMed ID: 21735852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Indirect costs in health technology assessment].
    Jakubczyk M; Wrona W; Macioch T; Golicki D; Niewada M; Hermanowski T
    Pol Merkur Lekarski; 2010 Jan; 28(163):42-5. PubMed ID: 20369723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transferability of valuing lost productivity across jurisdictions. differences between national pharmacoeconomic guidelines.
    Knies S; Severens JL; Ament AJ; Evers SM
    Value Health; 2010 Aug; 13(5):519-27. PubMed ID: 20712601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic cost of Guillain-Barré syndrome in the United States.
    Frenzen PD
    Neurology; 2008 Jul; 71(1):21-7. PubMed ID: 18591502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data.
    Merkesdal S; Ruof J; Huelsemann JL; Mittendorf T; Handelmann S; Mau W; Zeidler H
    Arthritis Rheum; 2005 Apr; 53(2):234-40. PubMed ID: 15818718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The indirect costs of arthritis resulting from unemployment, reduced performance, and occupational changes while at work.
    Li X; Gignac MA; Anis AH
    Med Care; 2006 Apr; 44(4):304-10. PubMed ID: 16565630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Workplace smoking related absenteeism and productivity costs in Taiwan.
    Tsai SP; Wen CP; Hu SC; Cheng TY; Huang SJ
    Tob Control; 2005 Jun; 14 Suppl 1(Suppl 1):i33-7. PubMed ID: 15923446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs and quality of life of multiple sclerosis in Austria.
    Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirect cost of ischemic heart disease to employers.
    Guico-Pabia CJ; Murray JF; Teutsch SM; Wertheimer AI; Berger ML
    Am J Manag Care; 2001 Jan; 7(1):27-34. PubMed ID: 11209448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The burden of illness associated with renal cell carcinoma in the United States.
    Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
    Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correcting for compensating mechanisms related to productivity costs in economic evaluations of health care programmes.
    Jacob-Tacken KH; Koopmanschap MA; Meerding WJ; Severens JL
    Health Econ; 2005 May; 14(5):435-43. PubMed ID: 15497201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs and quality of life for patients with multiple sclerosis in Belgium.
    Kobelt G
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S24-33. PubMed ID: 17318662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How do Italian pharmacoeconomists evaluate indirect costs?
    Garattini L; Tediosi F; Ghislandi S; Orzella L; Rossi C
    Value Health; 2000; 3(4):270-6. PubMed ID: 16464191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs and quality of life of multiple sclerosis in Switzerland.
    Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cost measurement based on a cost diary in patients with inflammatory bowel disease].
    Rösch M; Leidl R; Tirpitz Cv; Reinshagen M; Adler G; König HH
    Z Gastroenterol; 2002 Apr; 40(4):217-28. PubMed ID: 11961730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs and quality of life of multiple sclerosis in Italy.
    Kobelt G; Berg J; Lindgren P; Battaglia M; Lucioni C; Uccelli A
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S45-54. PubMed ID: 17310336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of cardiovascular diseases in the United Kingdom.
    Luengo-Fernández R; Leal J; Gray A; Petersen S; Rayner M
    Heart; 2006 Oct; 92(10):1384-9. PubMed ID: 16702172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs of illness: United States, 1980.
    Parsons PE; Lichtenstein R; Berki SE; Murt HA; Lepkowski JM; Stehouwer SA; Landis JR
    Natl Med Care Util Expend Surv C; 1986 Apr; (3):1-90. PubMed ID: 10313412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.